Benzodiazepine-Refractory Status Epilepticus - Which Drug is Second-Line?

December 27, 2019 00:23:35
Benzodiazepine-Refractory Status Epilepticus - Which Drug is Second-Line?
Critical Care Perspectives in Emergency Medicine
Benzodiazepine-Refractory Status Epilepticus - Which Drug is Second-Line?

Dec 27 2019 | 00:23:35

/

Show Notes

Up to one-third of patients with status epilepticus will not respond to benzodiazepines.  Unfortunately, treatment of benzodiazepine-refractory status epilepticus is not well studied.  The longer seizures persist, the worse patients do.  In this podcast, we discuss the results of the recently completed ESETT trial that evaluated three anticonvulsant medications for status epilepticus.

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode 0

March 04, 2019 00:28:51
Episode Cover

Troubleshooting the Trach

Respiratory distress in the patient with a tracheostomy can incite fear in even the most seasoned emergency physician or intensivist.  In this episode, we...

Listen

Episode

July 07, 2025 00:21:54
Episode Cover

Dexmedetomidine or Propofol for Sedation in the Critically Ill?

Critically ill patients receiving mechanical ventilation require analgesia and sedation.  At present, propofol remains the most widely used sedative for intubated/ventilated patients.  Recent trials...

Listen

Episode 0

June 15, 2020 00:24:08
Episode Cover

Diastolic Shock Index

Emergency medicine, critical care, and resuscitationists often use the Shock Index to identify patients with increased mortality.  The Shock Index is calculated by dividing...

Listen